España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Tilray Brands
TLRY
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.17
-0.03
-2.50%
At close: -
$1.17
0.00
0.00%
After Hours: 7:59 PM EDT
Get Report
Comment
Tilray Brands (TLRY) Forecast
News
Earnings
Tilray Brands (TLRY) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Tilray Brands (NASDAQ:TLRY) Stock
Tilray Brands Stock (NASDAQ: TLRY)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, January 15, 2025
Cannabis Legalization Headed For The Ballot Again In Florida: Advocates Launch New Amendment Initiative
Maureen Meehan
FDA Solicits Public Comments On Use Of Cannab...
Benzinga Newsdesk
Tuesday, January 14, 2025
Peering Into Tilray Brands's Recent Short Interest
Benzinga Insights
Friday, January 10, 2025
The Week In Cannabis: Tilray Earnings, NY Hits $1B In Sales, DoorDash Embraces Hemp, Ukraine And More
Javier Hasse
Cannabis/Beer Company Tilray Outlines Plan To Reduce Its Beverage Portfolio, Reports Mixed Q2 Earnings
Vandana Singh
Tilray Brands shares are trading lower after ...
Benzinga Newsdesk
Tilray Brands Reaffirms FY25 Guidance Of Anti...
Benzinga Newsdesk
Tilray Brands Q2 2025 Adj EPS $(0.00) Beats $...
Benzinga Newsdesk
Earnings Scheduled For January 10, 2025
Benzinga Insights
Thursday, January 09, 2025
Cannabis Stock Movers For January 9, 2025
Benzinga Insights
Wednesday, January 08, 2025
DEA Accused Of Bias In Cannabis Rescheduling Hearings: Weed Stocks Plummeted In 2024 As Process Drags On
Maureen Meehan
Monday, January 06, 2025
Tilray Medical Wins Contract to Supply Medica...
Benzinga Newsdesk
Friday, January 03, 2025
EXCLUSIVE: Cannabis Physician Says Surgeon General's Alcohol Cancer Risk Warning Is 'Wake-Up Call'
Maureen Meehan
Monday, December 30, 2024
Cannabis In 2025: Inside America's Social, Economic, Wellness Transformation
Maureen Meehan
Thursday, December 26, 2024
What's Going On With AMC Entertainment Stock?
Adam Eckert
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Tuesday, December 24, 2024
Top 10 Trending Stocks On WallStreetBets As O...
Benzinga Newsdesk
Why Carbon Revolution Shares Are Trading Higher By Around 62%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Monday, December 23, 2024
Top 10 Trending Stocks On WallStreetBets As O...
Benzinga Newsdesk
Tuesday, December 17, 2024
How Is The Market Feeling About Tilray Brands?
Benzinga Insights
Wednesday, December 11, 2024
Dropbox shares are trading higher after the c...
Benzinga Newsdesk
Tilray Brands Announced A New Holiday Campaig...
Benzinga Newsdesk
Monday, December 09, 2024
EXCLUSIVE: Drug Expert Dr. Carl Hart Slams Cannabis Prohibition Amid Hemp-THC Surge
Patricio Liddle
Thursday, December 05, 2024
Are You Missing Out On This NASDAQ-Listed Weed Stock? Low-Cost Model Meets European Demand
Nicolás Jose Rodriguez
Wednesday, December 04, 2024
Decibel Cannabis: One Acquisition Could Be The Key To Unlocking $20M In Cash Flow
Nicolás Jose Rodriguez
Hop Valley Brewing And Subsidiary Of Tilray B...
Benzinga Newsdesk
Monday, December 02, 2024
Court Of Chancery Of The State Of Delaware Ru...
Benzinga Newsdesk
Wednesday, November 27, 2024
'DEA Judge Won't Remove Agency From Marijuana...
Benzinga Newsdesk
Tuesday, November 26, 2024
DEA Says Formal Hearing Proceedings Regarding...
Benzinga Newsdesk
'Federal Health Officials 'Rejected' DEA's Re...
Benzinga Newsdesk
'Democratic Congressional Lawmakers Push Bide...
Benzinga Newsdesk
Tilray Introduces New Indica Strain With 'Potent THC And A Unique Terpene Profile'
Nina Zdinjak
Monday, November 25, 2024
Tom Angell Says "DEA says it is in the proces...
Benzinga Newsdesk
Saturday, November 23, 2024
Meta Faces Multibillion-Dollar Lawsuit As Supreme Court Dismisses Appeal In Cambridge Analytica Data Scandal
Ananya Gairola
Thursday, November 21, 2024
German Cannabis: 20 Tons, 10M Grams - And That's Only 0.3% Of The Market, What's Missing?
Nicolás Jose Rodriguez
Cannabis Stocks Feel The Burn: Matt Gaetz Bows Out As Trump's Attorney General Nominee
Nicolás Jose Rodriguez
Tuesday, November 19, 2024
How Is The Market Feeling About Tilray Brands?
Benzinga Insights
Friday, November 15, 2024
Shareholder Lawsuit Challenges Tilray's Voting Tactics For Authorized Share Increase
Rolando García
Tilray Joins German Cannabis Fiesta With First Locally Grown Strains
Rolando García
Thursday, November 14, 2024
CBD Pioneer Charlotte's Web Narrows Loss In Q3, Focuses On Long-Term Growth
Jelena Martinovic
Tilray Medical, A Division Of Tilray Brands A...
Benzinga Newsdesk
Wednesday, November 13, 2024
'Newly Elected Republican Senate Majority Lea...
Benzinga Newsdesk
Tuesday, November 12, 2024
Cannabis Stocks Pop Following Chris Christie's Prediction That Trump Will Deschedule Cannabis
Rolando García
Shares of cannabis-linked stocks are trading ...
Benzinga Newsdesk
Thursday, November 07, 2024
Cannabis Stocks: Is It Time To Buy The Dip After Elections And Legalization Setbacks?
Rolando García
Aurora vs. Canopy & Tilray: Which NASDAQ-Listed Cannabis Stock Offers The Best Growth Potential?
Nicolás Jose Rodriguez
Cannabis Extract Significantly Reduces Chemotherapy-Induced Vomiting, Tilray-Backed Study Reveals
Nina Zdinjak
Wednesday, November 06, 2024
Cannabis Stocks Collapse After Trump Win: Major Players See Double-Digit Declines At Wednesday's Close
Nicolás Jose Rodriguez
Tilray, Trulieve And Other Cannabis Stocks Nosediving As Industry Faces New Wave Of Political Uncertainty
Rolando García
Shares of cannabis stocks are trading lower a...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch